» Articles » PMID: 36709214

Xpert MTB/RIF Ultra CT Value Provides a Rapid Measure of Sputum Bacillary Burden and Predicts Smear Status in Patients with Pulmonary Tuberculosis

Overview
Journal Sci Rep
Specialty Science
Date 2023 Jan 28
PMID 36709214
Authors
Affiliations
Soon will be listed here.
Abstract

Traditionally, smear microscopy has been used to estimate bacillary burden in order to assess infectiousness in tuberculosis (TB) patients. Since Xpert MTB assays might replace smear microscopy as the first-line diagnostic test for pulmonary tuberculosis, an alternative measure of bacillary load that correlates with smear positivity is needed. This study assessed the correlation between C (with and without normalization), smear status, culture time-to-positivity (TTP), and clinical factors in patients with Xpert ultra positive sputum during a four-year period. A cut-off C value for smear positivity was also estimated. 204 samples were included. Strong correlation between both Xpert Ultra C values (raw and normalized) and smear status was obtained (r = 0.78 and - 0.79, respectively). The association between Raw-C and TTP was weaker than normalized-C (N-C) and TTP (r = 0.50 and r = - 0.70, respectively). A Raw-C cut-off value of 21.4 was identified with 85.7% (95% CI 65.4-95) sensitivity and 92.9% (95% CI 84.3-96.9) specificity. A N-C cut-off value of 5.2 yielded a sensitivity of 94.3% (95% CI 86.2-97.8) and specificity of 85.7% (95% CI 65.4-95). Our study demonstrates that Xpert Ultra C value correlates well with other measures of bacillary load such as smear status or TTP. The correlation with TTP is stronger when the C value is normalized using the internal control. The proposed N-C cut-off value of 5.2 shows a better sensitivity than the Raw-CT when predicting smear positive status.

Citing Articles

Real-world clinical utility of Xpert MTB/RIF Ultra in the assessment of tuberculosis in a low-TB-incidence, high-resource setting.

Kim J, Patel H, Halliwell R, Free R, Glimour-Caunt A, Pareek M BMJ Open Respir Res. 2025; 12(1.

PMID: 39832887 PMC: 11751901. DOI: 10.1136/bmjresp-2024-002624.


Usefulness of Xpert MTB/RIF and Xpert Ultra to Categorize Risk of Tuberculosis Transmission to Household Contacts.

Mol A, Sanchez-Montalva A, Espinosa-Pereiro J, Aznar M, Salvador F, Bosch-Nicolau P Open Forum Infect Dis. 2024; 11(8):ofae450.

PMID: 39165580 PMC: 11334063. DOI: 10.1093/ofid/ofae450.


Accuracy of C-Reactive Protein for Tuberculosis Detection in General-Population Screening and Ambulatory-Care Triage in Uganda.

Cox S, Erisa K, Kitonsa P, Nalutaaya A, Nantale M, Kayondo F Ann Am Thorac Soc. 2024; 21(6):875-883.

PMID: 38259069 PMC: 11160129. DOI: 10.1513/AnnalsATS.202308-752OC.

References
1.
Lopez-Roa P, Martin-Higuera C, Ruiz-Serrano M, Toro C, Tato M, Simon M . Performance of Xpert MTB/RIF Ultra assay on respiratory and extra-respiratory samples in a high-resource setting with a low tuberculosis prevalence. Diagn Microbiol Infect Dis. 2020; 99(2):115235. DOI: 10.1016/j.diagmicrobio.2020.115235. View

2.
van Zyl-Smit R, Binder A, Meldau R, Mishra H, Semple P, Theron G . Comparison of quantitative techniques including Xpert MTB/RIF to evaluate mycobacterial burden. PLoS One. 2012; 6(12):e28815. PMC: 3245241. DOI: 10.1371/journal.pone.0028815. View

3.
Theron G, Venter R, Smith L, Esmail A, Randall P, Sood V . False-Positive Xpert MTB/RIF Results in Retested Patients with Previous Tuberculosis: Frequency, Profile, and Prospective Clinical Outcomes. J Clin Microbiol. 2018; 56(3). PMC: 5824043. DOI: 10.1128/JCM.01696-17. View

4.
Hanrahan C, Theron G, Bassett J, Dheda K, Scott L, Stevens W . Xpert MTB/RIF as a measure of sputum bacillary burden. Variation by HIV status and immunosuppression. Am J Respir Crit Care Med. 2014; 189(11):1426-34. PMC: 4098085. DOI: 10.1164/rccm.201312-2140OC. View

5.
Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S . Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med. 2011; 184(1):132-40. DOI: 10.1164/rccm.201101-0056OC. View